Table 1.

Patients’ characteristics

Eligible patients (n)	35
Evaluable patients (n)	34
Age (median, range) (years)	51 (26–81)
Performance status (WHO) (n)
0–1	32
>1	2
Metastatic site
Skin + node + subcutaneous tissue	18
Lung	11
Visceral + bone	5
Prior treatment (n)
Surgery	32
Chemotherapy	8
Radiotherapy	3
Interferon	1
Treatment doses (n)
<5	4
5–10	14
>10	16

Abbreviation: WHO, World Health Organization.